{"version":"1.0","provider_name":"Sygnature","provider_url":"https:\/\/www.sygnaturediscovery.com\/fr\/","author_name":"Mia","author_url":"https:\/\/www.sygnaturediscovery.com\/fr\/author\/mia\/","title":"High throughput screening of inverse agonists - Sygnature","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"Utvq8YKzop\"><a href=\"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/high-throughput-screening-of-inverse-agonists\/\">High throughput screening of inverse agonists<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.sygnaturediscovery.com\/fr\/blog\/high-throughput-screening-of-inverse-agonists\/embed\/#?secret=Utvq8YKzop\" width=\"600\" height=\"338\" title=\"&laquo; High throughput screening of inverse agonists &raquo; &#8212; Sygnature\" data-secret=\"Utvq8YKzop\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.sygnaturediscovery.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/02\/sygnature-hit-to-lead-team-collaboration-scaled.webp","thumbnail_width":2560,"thumbnail_height":1707,"description":"Explore our innovative approach to screening GPCR inverse agonists and discover the therapeutic potential of these compounds in drug discovery. Learn how we developed robust HTS assays, screened hundreds of compounds, and advanced our drug discovery pipeline with precision and efficiency."}